Mouse IL-1ra/IL-1F3 Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAF480
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Specificity
Clonality
Host
Isotype
Applications for Mouse IL-1ra/IL-1F3 Biotinylated Antibody
Western Blot
Sample: Recombinant Mouse IL-1ra/IL-1F3 (Catalog # 480-RM)
Mouse IL-1ra/IL-1F3 Sandwich Immunoassay
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-1ra/IL-1F3
IL-1ra was originally isolated from the urine of patients with monocytic leukemia and has also been purified from adherent monocytes. The naturally-occurring, fully glycosylated form has an apparent molecular weight of about 25,000 Daltons. The protein shows 26% amino acid homology to IL-1 beta and 19% homology to IL-1 alpha. It will compete with either factor for receptor binding, but does not interact with either one. Human IL-1ra will bind to both types of IL-1 receptor (I and II) on human cells. In mouse, IL-1 RII does not bind IL-1ra. IL-1ra has been shown to block the inflammatory responses induced by IL-1 both in vitro and in vivo. Pre-clinical and clinical studies were done to test possible therapeutic applications for IL-1ra in the treatment of sepsis, rheumatoid arthritis and chronic myelogenous leukemia.
Long Name
Alternate Names
Gene Symbol
Additional IL-1ra/IL-1F3 Products
Product Documents for Mouse IL-1ra/IL-1F3 Biotinylated Antibody
Product Specific Notices for Mouse IL-1ra/IL-1F3 Biotinylated Antibody
For research use only